Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus-Reference-Cited by-同舟云学术

Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus

Published:2011-11 Issue:11 Volume:22 Page:1343-1353
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Wongthida Phonphimon¹,Diaz Rosa Maria¹²,Pulido Christine¹,Rommelfanger Diana¹,Galivo Feorillo¹,Kaluza Karen¹²,Kottke Timothy¹,Thompson Jill¹,Melcher Alan³,Vile Richard¹²³

Affiliation:

1. Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905.

2. Department of Immunology, Mayo Clinic, Rochester, MN 55905.

3. Institute of Molecular Medicine, University of Leeds, Leeds, LS9 7TF, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2010.216

Reference47 articles.

1. Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow

2. Potentiating Cancer Immunotherapy Using an Oncolytic Virus

3. Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

4. A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

5. Oncolytic Immunovirotherapy for Melanoma Using Vesicular Stomatitis Virus

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?;Vaccines;2024-06-28

2. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens;Frontiers in Immunology;2024-01-03

3. Personalizing Oncolytic Immunovirotherapy Approaches;Molecular Diagnosis & Therapy;2023-12-27

4. Construction of VSVΔ51M oncolytic virus expressing human interleukin-12;Frontiers in Molecular Biosciences;2023-05-15

5. Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular monocytes;Communications Biology;2022-12-19